Life Settlement vs. Viatical Settlement: What's the Difference?
Selling a life insurance policy instead of letting it lapse sounds like a single idea, but the terms used to describe it actually split into two related transactions that hinge on one key detail.
The short answer
A life settlement and a viatical settlement both involve selling an existing life insurance policy to a third party for a lump-sum cash payment, with the buyer taking over premiums and eventually collecting the death benefit. The main difference is health status: a viatical settlement specifically applies to policyholders with a qualifying terminal or chronic illness and a limited life expectancy, while a life settlement is the broader term generally used when no such diagnosis is involved.
Where the two overlap
Structurally, both transactions work the same way. The policyholder transfers ownership and beneficiary rights to a buyer, receives cash upfront, and gives up any future death benefit that would otherwise go to their own beneficiaries. Both are alternatives to simply surrendering a policy back to the original insurer for its cash value, and in both cases, the amount offered depends on factors like the policy’s face value, ongoing premium costs, and the insured person’s expected life expectancy.
Where they diverge
- Qualifying condition. A viatical settlement requires a terminal or chronic illness diagnosis with a limited life expectancy, documented by a physician. A life settlement generally doesn’t require any specific health condition, though age and health still affect pricing.
- Typical seller profile. Viatical settlements are more often used by people facing a serious diagnosis who need funds for medical care or related costs. Life settlements are more often used by older policyholders whose coverage no longer fits their needs or budget, regardless of a specific illness.
- Pricing tendencies. Because a viatical settlement buyer generally expects a shorter holding period before the policy pays out, the settlement amount is often a higher percentage of the face value than in a typical life settlement, though this varies by individual case.
- Regulatory treatment. Some states and tax rules distinguish between the two categories, which can affect how proceeds are treated, though this depends on individual circumstances and rules that are set by the government and can change over time.
Why the distinction matters in practice
Someone shopping for either type of transaction benefits from knowing which category applies to them, since it affects which buyers are relevant, what documentation will be requested, and roughly what portion of the face value might be offered. Confusing the two isn’t usually harmful by itself, but it can lead to unrealistic expectations about pricing if a policyholder without a qualifying illness expects viatical-level offers.
What both still have in common
Neither transaction is reversible once completed, and in both cases the original policy’s riders or special features typically transfer to the buyer along with the base coverage, which means the seller gives those up as well. Both also generally require full disclosure of the policy’s history and, for a viatical settlement, medical records supporting the diagnosis.
The takeaway
The core idea, selling a policy instead of surrendering or lapsing it, is shared between a life settlement and a viatical settlement. The dividing line is the seller’s health situation: a qualifying terminal or chronic illness points toward a viatical settlement, while its absence points toward the broader life settlement category. Either way, the trade-off is the same in kind, cash now in exchange for giving up a future death benefit, so it’s worth weighing carefully regardless of which term applies.